Regulus Therapeutics
RGLS
#7200
Rank
โ‚ฌ0.51 B
Marketcap
7,44ย โ‚ฌ
Share price
0.00%
Change (1 day)
464.48%
Change (1 year)

EPS for Regulus Therapeutics (RGLS)

EPS in 2025 (TTM): -0,68ย โ‚ฌ

According to Regulus Therapeutics's latest financial reports the company's current EPS (TTM) is -0,67ย โ‚ฌ. In 2024 the company made an earnings per share (EPS) of -0,79ย โ‚ฌ.

EPS history for Regulus Therapeutics from 2013 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-0,68ย โ‚ฌ-14.54%
2024-0,79ย โ‚ฌ
2022-1,70ย โ‚ฌ-43.12%
2021-2,98ย โ‚ฌ-40.55%
2020-5,01ย โ‚ฌ-50%
2019-10,03ย โ‚ฌ-80.36%
2018-51,05ย โ‚ฌ-57.8%
2017-120,97ย โ‚ฌ-28.66%
2016-169,56ย โ‚ฌ42.2%
2015-119,24ย โ‚ฌ-14.84%
2014-140,02ย โ‚ฌ156%
2013-54,70ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Sanofi
SNY
1,81ย โ‚ฌ-371.31%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
2,15ย โ‚ฌ-423.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
4,12ย โ‚ฌ-719.18%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
6,49ย โ‚ฌ-1,075.34%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
2,62ย โ‚ฌ-494.16%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sangamo Therapeutics
SGMO
-0,35ย โ‚ฌ-47.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
18,06ย โ‚ฌ-2,813.70%๐Ÿ‡บ๐Ÿ‡ธ USA